<DOC>
	<DOCNO>NCT00163930</DOCNO>
	<brief_summary>This project seek evaluate effectiveness new post-operative pain relief program woman undergo uterine artery embolisation ( UAE ) . UAE perform interventional radiologist treatment uterine fibroid ( non-cancerous growth uterus . ) UAE associate high level post-procedural pain purpose study evaluate new relief regimen deal acute pain . There two treatment group patient randomly assign . One receive current post-operative therapy ( dose-on-demand ) receive new therapy ( pre-emptive dosing ) . Otherwise patient receive standard management protocol procedure . Only patient schedule UAE enrol ( 40 patient ) . The new treatment involve give patient morphine dose orally sixty minute procedure begin ( pre-emptive dosing ) oppose current standard treatment involve give patient dose morphine intravenously feel pain . Information collect directly patient include pain nausea level , indicate visual scale ( 10 centimetre line show spectrum pain bad pain imaginable ) well opinion effectiveness pain relief program procedure . This information collect immediately post-procedure 2 , 4 , 6 24 hour post procedure . Each VAS take patient approximately 20 second complete . Information concurrent medication procedure complication , post-operative vomit respiratory depression collect patient ’ history .</brief_summary>
	<brief_title>Post-Operative Pain Management Patients Undergoing Uterine Artery Embolisation Symptomatic Leiomyomata</brief_title>
	<detailed_description>Post operative Pain Management Paitents Undergoing Uterine Artery Embolisation Symptomatic Leiomyomata Protocol ( Ver 2.1 ) 1.1 Research Question Does pre emptive morphine dose help reduce acute post operative pain ( express visual analogue scale , VAS ) and/or post operative opioid use patient undergoing uterine artery embolisation ? 2.1 Enrolment Patients enrol Prof Ken Thomson Dr Stuart Lyon plan consultation woman . They require sign consent form choose participate point . 3 photocopy consent form take , one copy go : patient ; history ; data file . 2.2 Exclusions Patients follow exclude study : - Pregnancy - Contrast allergy - Allergy one treatment drug - History alcoholism - Diagnosed hepatic disease - Renal insufficiency - Acute pelvic infection - Endometrial carcinoma - Undiagnosed pelvic mass - Non English speaking patient - Patients require post op non opioid analgesia 3.1 Randomisation blind The placebo oxycontinSR tablet pre randomised clinical trial pharmacy LG level ( Ann Mak ) . 4.1 Pre medication The trial drug ( oxycontin ) order yellow clinical trial prescription form . A day patient arrives , form fax Clinical Trials Pharmacy ( Fax No 3305 ) . A registered nurse ward researcher pick drug Clinical Trials Pharmacy LG level . The non trial medication either already ward order via pharmacy per normal . The trial drug pre medication write prepared drug chart give ward . 4.2 Treatment The ward staff administer drug prescribe drug chart 60 +/- 20 minute prior procedure . The difference treatment show follow table . Dose demand treatment Pre emptive treatment 1 hour surgery : - Paracetamol 1.5g - Temazepam 20mg - Placebo OxycontinSR - Piroxicam ( Feldene ) 20mg - Ondansetron 8mg 1 hour surgery : - Paracetamol 1.5g - Temazepam 20mg - OxycontinSR - Piroxicam ( Feldene ) 20mg - Ondansetron 8mg Surgery : - PCA morphine - 1mg dose 5 minute lockout Surgery : - PCA morphine - 1mg dose 5 minute lockout Follow - Endone 5-10mg oral 4/24 prn Follow - Endone 5-10mg oral 4/24 prn The ward staff blind treatment patient receive since pre med randomise blinded pharmacy . 5.1 Post op Pain nausea measurement take 2 , 4 , 6 24 hour use visual analogue scale ( VAS ) questionnaire sheet . This do either researcher , time permit , ward staff . Drug related side effect also record , respiratory depression vomit therefore important carefully document patient ’ history . 5.2 Deviations pain management protocol There may instance PCA deliver adequate pain relief . It may necessary case deviate pain management protocol comfort patient . This necessarily exclude patient study . However , way data interpret non opioid analgesia give do caution . Deviations institute : - Obvious drug relate side effect evident ( e.g . respiratory depression , narcosis ) ; - Pain acceptable level 6 hour post procedure ; - Pain level keep routine post UAE pain report nursing medical staff . Please notify Dr Stuart Lyon Dr Jeff Tam ( ex 3606 ) Pain Team need intervene patient . They assess whether patient exclude study . 6.1 Discharge When patient deem ready discharge need take home discharge pack questionnaire fill home . These do 24 hour post procedure . The pack include : - Pain VAS - Nausea VAS - Overall pain relief rating VAS - UAE procedure rating VAS - Instructions sheet - Reply pay , self address envelope Please check 2 , 4 6 hour questionnaire fill patient discharge , leave discharge pack . Once complete , questionnaires send back Radiology Research Department . Most patient discharge within 24 hour procedure . In event patient stay hospital longer 24 hour , discharge pack complete 24 hour mark . The complete data sheet send back Radiology Research Department . If data sheet receive within 2 week discharge , researcher make phone call patient enquire whether complete answer question patient may .</detailed_description>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<mesh_term>Pain , Postoperative</mesh_term>
	<criteria />
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Uterine Fibroids</keyword>
	<keyword>embolisation</keyword>
	<keyword>pain management</keyword>
</DOC>